Cargando…
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
SIMPLE SUMMARY: Differentiated thyroid cancer includes papillary (PTC) and follicular thyroid cancer (FTC). Eighty-five percent of patients are cured by thyroidectomy and one single radioiodine treatment. Relapse is rare and can mostly be cured by a second radioiodine therapy. Between 5% and 10% of...
Autores principales: | Chiapponi, Costanza, Hartmann, Milan J. M., Schmidt, Matthias, Faust, Michael, Schultheis, Anne M., Bruns, Christiane J., Alakus, Hakan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699287/ https://www.ncbi.nlm.nih.gov/pubmed/34944849 http://dx.doi.org/10.3390/cancers13246230 |
Ejemplares similares
-
Differentiated Thyroid Cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment
por: Chiapponi, Costanza, et al.
Publicado: (2023) -
Salvage surgery for cervical radioiodine refractory (18)F-FDG-PET positive recurrence of papillary thyroid cancer
por: Chiapponi, C, et al.
Publicado: (2021) -
Hürthle Cell Carcinoma: Single Center Analysis and Considerations for Surgical Management Based on the Recent Literature
por: Chiapponi, Costanza, et al.
Publicado: (2022) -
Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer
por: Chiapponi, Costanza, et al.
Publicado: (2022) -
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis
por: Hescheler, Daniel A., et al.
Publicado: (2021)